CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF MEDICAL OFFICER sold 29,325 shares at $32.55 ($954,529)
- 4 Planned sale CHIEF OPERATING OFFICER sold 138,614 shares at an average $33.20 ($4,602,370)
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 18,889 shares at $32.89 ($621,259)
- 4 Planned sale CHIEF ACCOUNTING OFFICER sold 17,000 shares at $32.35 ($549,950)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Option exercise Director acquired 64,508 shares (option exercise)
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale CHIEF OPERATING OFFICER sold 18,900 shares at $28.72 ($542,808)
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Option exercise Director acquired 1,101 shares (option exercise)
Page 8 of 39 · 778 filings